Sanegene Bio
Latest round
- Series B
Last raised
- Dec 2025
Total raised
- $270M
Investors
- 26
About Sanegene Bio
, trading as Sanegene Bio, operates as a pharmaceutical developer dedicated to developing novel RNAi therapeutics. The founder and CEO of the company, Weimin Wang has worked at Dicerna Pharmaceuticals. The CSO of the company, Shiyu Wang has worked in Ionis Pharmaceutical and Dicerna Pharmaceuticals. The company mainly develops RNAi therapeutics and pharmaceuticals through a chemical modification platform and hepatic and extrahepatic delivery platforms. The first RNAi drug SGB-3403 has entered the clinical stage, which is for the treatment of hypercholesterolemia. The company's revenue is generated by providing RNAi therapeutics and pharmaceuticals.
Who invested in Sanegene Bio
26 investors across 3 rounds
See all investors in Sanegene Bio
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Sanegene Bio
Who invested in Sanegene Bio?
Sanegene Bio has 26 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Sanegene Bio raised?
Sanegene Bio has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Sanegene Bio last raise money?
Sanegene Bio's most recent round on record is a Series B, in Dec 2025.
What does Sanegene Bio do?
, trading as Sanegene Bio, operates as a pharmaceutical developer dedicated to developing novel RNAi therapeutics.
Where is Sanegene Bio headquartered?
Sanegene Bio is headquartered in Woburn, US.
Which VCs invest in companies like Sanegene Bio?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Sanegene Bio's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Sanegene Bio? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.